Interleukin-10

Phase 1Protein / enzyme

NNational Institute of Allergy and Infectious Diseases (NIAID)

Interleukin-10 is one of 24 small molecule programs targeting Granuloma. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GranulomaActive, not recruiting

GranulomaPhase 1

Active, not recruiting

Competition

Competitive Landscape

35 competitors in Granuloma

#DrugCompanyPhaseTrials

Medrol

Pfizer

Approved

1 2

Rayos

RRoxane Laboratories

Approved

1 3

Compound Betamethasone

SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Approved

1 4

Enbrel

IImmunex

Phase 3

2 5

Nexium

DDexcel Pharma Technologies Ltd.

Phase 3

1 6

Zinbryta

Roche

Phase 2

1 7

Intron a

Sanofi

Phase 2

1 8

Olumiant

Eli Lilly

Phase 2

1 9

Orencia

Bristol-Myers Squibb

Phase 2

1 10

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Granuloma1 trial

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00001761·15 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Interleukin-10. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Interleukin-10 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Interleukin-10. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Institute of Allergy and Infectious Diseases (NIAID) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Protein / enzyme[2]
Highest Phase: Phase 1[1]
Company: NNational Institute of Allergy and Infectious Diseases (NIAID)

Interleukin-10

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Granuloma1 trial

References

Drug Info

Quick Facts

Related News